Related Experiment Video
Updated: Aug 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2
Shaik Ohidar Rahaman1, Michael A Vogelbaum, S Jaharul Haque
1Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Ohio 44195, USA.
Abstract:
Interleukin (IL)-4 exhibits antitumor activity in rodent experimental gliomas, which is likely mediated by the actions of IL-4 on a variety of immune cells present in and around the tumor masses. Here, we show that IL-4, which activates Stat6 in normal human astrocytes and in a variety of other cells, induces an aberrant activation of Stat3 in glioblastoma multiforme (GBM) cells but not in normal human astrocytes. Previously, we have shown that autocrine IL-6 signaling induces a persistent activation of Stat3. Now, we show that Stat3 is further activated by IL-4 stimulation of GBM cells. Expression of IL-13Ralpha2, a decoy receptor for IL-13 that partly blocks IL-4-mediated activation of Stat6 in GBM cells, up-regulates the activation of Stat3 as shown by a small interfering RNA-mediated inhibition of IL-13Ralpha2 expression. In addition, transient expression of the IL-13Ralpha2 transgene in 293T cells increases the IL-4-mediated activation of Stat3 and subsequent expression of Stat3-targeted gene. Coimmunoprecipitation results reveal that IL-13Ralpha2-mediated activation of Stat3 does not require a direct physical interaction between Stat3 and IL-13Ralpha2. Chromatin immunoprecipitation assay employing anti-Stat3 antibody confirms the in vivo binding of activated Stat3 to the promoters of genes that encode antiapoptotic proteins Bcl-2, Bcl-x(L), and Mcl-1. IL-4 significantly up-regulates of the steady-state levels of Bcl-2, Bcl-x(L), and Mcl-1 in GBM cells. These results indicate that IL-4/IL-13 receptor-mediated Stat3 signaling may contribute to the pathogenesis of GBM cells by modulating the expression of the Bcl-2 family of antiapoptotic proteins.
Insights
Interleukin-4 (IL-4) activates Stat3 in glioblastoma cells, unlike in normal astrocytes. This IL-4-induced Stat3 activation promotes glioblastoma cell survival by upregulating antiapoptotic proteins.
Area of Science:
- Neuro-oncology
- Immunology
- Molecular Biology
Background:
- Interleukin-4 (IL-4) demonstrates antitumor effects in rodent gliomas, primarily through immune cell modulation.
- IL-4 typically activates Stat6 in normal cells, but its role in glioblastoma multiforme (GBM) involves aberrant signaling pathways.
Purpose of the Study:
- To investigate the mechanism of IL-4-induced signaling in glioblastoma multiforme (GBM) cells.
- To determine if IL-4 influences Signal Transducer and Activator of Transcription 3 (Stat3) activation in GBM.
- To explore the downstream effects of IL-4-mediated Stat3 activation on GBM cell survival.
Main Methods:
- Utilized cell lines including normal human astrocytes and glioblastoma multiforme (GBM) cells.
- Investigated Signal Transducer and Activator of Transcription (Stat) activation using Western blotting and co-immunoprecipitation.
- Assessed gene expression changes using chromatin immunoprecipitation assays and quantitative PCR.
- Manipulated expression of IL-13 receptor alpha 2 (IL-13Ralpha2) using small interfering RNA and transgene expression.
Main Results:
- IL-4 induced aberrant Stat3 activation in GBM cells, but not in normal human astrocytes.
- IL-13Ralpha2 expression modulated IL-4-mediated Stat3 activation, with inhibition of IL-13Ralpha2 upregulating Stat3 activation.
- Activated Stat3 was confirmed to bind the promoters of antiapoptotic genes: Bcl-2, Bcl-x(L), and Mcl-1.
- IL-4 significantly increased the expression of Bcl-2, Bcl-x(L), and Mcl-1 in GBM cells.
Conclusions:
- IL-4 signaling, potentially through the IL-4/IL-13 receptor complex, aberrantly activates Stat3 in GBM cells.
- IL-4-mediated Stat3 activation contributes to GBM pathogenesis by upregulating antiapoptotic proteins, promoting cell survival.
- Targeting this pathway could offer novel therapeutic strategies for glioblastoma.
Related Concept Videos
The JAK-STAT Signaling Pathway
Abnormal Proliferation
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Intracellular Signaling Affects Focal Adhesions
Some...
